We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$122B
AUM Growth
+$51B
Cap. Flow
+$46.1B
Cap. Flow %
37.82%
Top 10 Hldgs %
12.48%
Holding
2,601
New
156
Increased
1,070
Reduced
644
Closed
53

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.39B
2
AAPL icon
Apple
AAPL
+$1.66B
3
AMZN icon
Amazon
AMZN
+$1.51B
4
META icon
Meta Platforms (Facebook)
META
+$1.24B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.16B

Top Sells

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$644M
2
CAT icon
Caterpillar
CAT
+$266M
3
DKNG icon
DraftKings
DKNG
+$140M
4
ORCL icon
Oracle
ORCL
+$123M
5
EQR icon
Equity Residential
EQR
+$112M

Sector Composition

Rank Sector Weight
1 Technology 24.17%
2 Healthcare 14.82%
3 Financials 12.96%
4 Consumer Discretionary 10.52%
5 Industrials 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KFRC icon
2151
Kforce
KFRC
$983M
$38K ﹤0.01%
606
-129
-18% -$7.64K
PNTG icon
2152
Pennant Group
PNTG
$1.43B
$38K ﹤0.01%
919
PRCH icon
2153
Porch Group
PRCH
$1.3B
$38K ﹤0.01%
+1,963
New +$32.4K
RYTM icon
2154
Rhythm Pharmaceuticals
RYTM
$7B
$38K ﹤0.01%
1,930
+1,463
+313% +$30.4K
VHC icon
2155
VirnetX Holding Corp
VHC
$52.3M
$38K ﹤0.01%
447
RVNC
2156
DELISTED
Revance Therapeutics, Inc.
RVNC
$38K ﹤0.01%
1,283
SRNE
2157
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$38K ﹤0.01%
3,972
CVA
2158
DELISTED
Covanta Holding Corporation
CVA
$38K ﹤0.01%
2,181
ORBC
2159
DELISTED
ORBCOMM, Inc.
ORBC
$38K ﹤0.01%
3,421
ANF icon
2160
Abercrombie & Fitch
ANF
$4.17B
$37K ﹤0.01%
788
AXDX
2161
DELISTED
Accelerate Diagnostics
AXDX
$37K ﹤0.01%
+461
New +$36.6K
BNGO icon
2162
Bionano Genomics
BNGO
$12.7M
$37K ﹤0.01%
+8
New +$31.6K
INSW icon
2163
International Seaways
INSW
$4.57B
$37K ﹤0.01%
1,907
MODV
2164
DELISTED
ModivCare
MODV
$37K ﹤0.01%
215
-184
-46% -$27.6K
PFC
2165
DELISTED
Premier Financial Corp. Common Stock
PFC
$37K ﹤0.01%
1,296
ACMR icon
2166
ACM Research
ACMR
$5.83B
$36K ﹤0.01%
1,056
HCI icon
2167
HCI Group
HCI
$2.28B
$36K ﹤0.01%
360
VICR icon
2168
Vicor
VICR
$9.62B
$36K ﹤0.01%
343
EPC icon
2169
Edgewell Personal Care
EPC
$1.27B
$35K ﹤0.01%
786
-552
-41% -$23.4K
GHC icon
2170
Graham Holdings Company
GHC
$4.97B
$35K ﹤0.01%
55
-15
-21% -$9.66K
GVA icon
2171
Granite Construction
GVA
$5.45B
$35K ﹤0.01%
849
HURN icon
2172
Huron Consulting
HURN
$1.82B
$35K ﹤0.01%
718
NPO icon
2173
Enpro
NPO
$7.05B
$35K ﹤0.01%
360
FIZZ icon
2174
National Beverage
FIZZ
$2.87B
$34K ﹤0.01%
+720
New +$34.9K
HCKT icon
2175
Hackett Group
HCKT
$245M
$34K ﹤0.01%
1,861

Similar funds

Macquarie Group's Q2 2021 Portfolio in Review

As of Q2 2021, Macquarie Group held 2,601 positions worth $122B, up 72% from $70.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Macquarie Group deployed $46.1B of net new capital in Q2 2021, opening 156 new positions and adding to 1,070 existing holdings. Its largest new stake was Canada Goose Holdings: 4,239,426 shares worth $185M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Mondelez International, an estimated $644M trimmed.

  • Macquarie Group's largest Q2 2021 buy was Canada Goose Holdings: 4,239,426 shares worth $185M.
  • Macquarie Group added most to Microsoft in Q2 2021, an estimated $2.39B increase.
  • Macquarie Group's biggest Q2 2021 reduction was Mondelez International, cutting an estimated $644M.
  • Macquarie Group fully exited GenMark Diagnostics, Inc in Q2 2021, selling an estimated $60.9M.
  • Macquarie Group's ten largest holdings make up 12% of its $122B portfolio in Q2 2021.
  • Macquarie Group opened 156 new positions and closed 53 in Q2 2021.
  • Macquarie Group's portfolio value rose 72% quarter-over-quarter to $122B.

Based on Macquarie Group's 13F filing for Q2 2021, filed 13 Aug 2021.